Industry News

Medical Device Industry News

Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi Drug-Resistant Prosthetic Joint Infection (PJI) Under an Expanded Access Chronic Care Management Protocol

July 10th, 2026|Medical Device News Magazine|

Lysins are a promising new family of enzyme-based antimicrobials which offer unique properties compared to antibiotics <p>The post Precisio Biotix Therapeutics, Inc. (Precisio) Announces the Use of Its ClyO (Staph Lysin) to Treat a Multi

Terumo’s ROADSAVER™ Carotid Stent System: Leading the Evolution of Carotid Artery Stenting | By Tim Hoeman, Vice President, Marketing, Terumo Interventional Systems

July 7th, 2026|Medical Device News Magazine|

The ROADSAVER Stent System is a next-generation design featuring an innovative, dual-layer nitinol micromesh construction. The outer self-expanding nitinol scaffold provides strength and flexibility, while the inner micromesh layer serves as a continuous embolic barrier

Trilogy Laboratories Acquires YNS Cosmeceuticals, Bringing Pharmaceutical Expertise and Physician Leadership to a Trusted Skincare Brand

July 2nd, 2026|Medical Device News Magazine|

The acquisition combines YNS's established skincare philosophy with Trilogy Laboratories' pharmaceutical formulation expertise, FDA-registered manufacturing capabilities, and physician leadership to guide the brand's next stage of growth The post Trilogy Laboratories Acquires YNS Cosmeceuticals, Bringing

Medical Devices Are Becoming Ecosystems | Safety Programs Must Adapt | By Dr. Padmalakshmi Jnaneshwar, Director of Safety Operations, Lifecycle Safety at IQVIA

July 1st, 2026|Medical Device News Magazine|

Medical devices have evolved to the point where they no longer operate as standalone products. As these products become more connected, materiovigilance, the process of monitoring and evaluating the safety and performance of medical devices

Remepy Publishes New Evidence Showing its Hybrid Drug, HybridopaTM, Effect on Structural Connectivity in the Brain of Parkinson’s Patients Associated with Improved Clinical Outcome

July 1st, 2026|Medical Device News Magazine|

These findings further strengthen the mechanistic and translational rationale of Hybridopa™ and support its progression toward a Phase III clinical trial The post Remepy Publishes New Evidence Showing its Hybrid Drug, HybridopaTM, Effect on Structural